Koa Health, a digital mental healthcare provider offering personalized solutions backed by science, closed a €30m ($36m) Series A funding round.
The round had a first close in October 2020, led by Wellington Partners Life Sciences and Ancora Finance Group, and has now been fully closed with key participations from MTIP and Akilia Partners, and further contributions from Creas Impacto, Sabadell Asabys, and Mundi Ventures. In conjunction with the funding, David Germonpré, Partner at MTIP, who joins the Board of Directors.
The company intends to use the funds to accelerate product development, expand US presence, and enhance R&D.
Led by Oliver Harrison, CEO, Koa provides Koa Foundations, a mental wellbeing app that helps organizations better support employees with a library of evidence-based activities focused on tackling stress, sleeping better, aiding relaxation and positive thinking and boosting self confidence. Koa Foundations is available to more than three million people through contracts with dozens of employers, healthcare providers and payers.
Koa Health already works closely with a range of renowned organizations, including Massachusetts General Hospital, a top US-ranked hospital for both psychiatry and psychology, The Max Planck UCL Centre for Computational Psychiatry and Aging Research in London, and the Birmingham and Solihull Mental Health NHS Foundation Trust in the UK.
The company has operations in Barcelona, the US and the UK.